key: cord-0855429-mqwtwszd authors: Ji, Ye; Shao, Jun; Tao, Bilin; Song, Huan; Li, Zhongqi; Wang, Jianming title: Are we ready to deal with a global COVID-19 pandemic? Rethinking countries' capacity based on the Global Health Security Index date: 2021-04-03 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2021.03.089 sha: 822bd5804785e4ad1821ce86a752d0fe16d4c260 doc_id: 855429 cord_uid: mqwtwszd Background The Global Health Security (GHS) Index has been developed to measure a country’s capacity to cope with a public health emergency but evidence for whether it corresponds to the response to a global pandemic is lacking. In the current study, we performed a multidimensional association analysis to explore the correlation between the GHS Index and COVID-19-associated morbidity, mortality, and disease increase rate (DIR) in 178 countries (regions). Methods GHS Index and COVID-19 epidemic data were extracted from online databases, including total cases per million (TCPM), total deaths per million (TDPM), and daily growth rate. We applied the Spearman correlation coefficient to describe the strength of the association between the GHS Index, sociological characteristics, and the epidemic situation of COVID-19. DIRs were compared, and the impact of the GHS Index on the DIR by the time of “lockdown” was visualized. Results The overall GHS Index was positively correlated with TCPM and TDPM, with coefficients of 0.34 and 0.41, respectively. Countries categorized into different GHS Index tiers had different DIRs before implementing “lockdown” measures. However, after implementing “lockdown” measures, no significant difference was observed between countries in the middle and upper tiers. The correlation between GHS Index and DIR was positive five days before “lockdown” measures were taken, but it became negative 13 days later. Conclusions The GHS Index has limited value in assessing a country's capacity to respond to a global pandemic. Nevertheless, it has potential value in determining the country’s ability to cope with a local epidemic situation. past two decades and caused large-scale disease outbreaks (Cui et al., 2019) . For example, severe acute respiratory syndrome (SARS) was first reported in Asia in 2003 and then quickly spread to 26 countries, resulting in over 8,000 cases and 774 deaths (de Wit et al., 2016) . In 2012, Middle East respiratory syndrome (MERS) emerged in Saudi Arabia and spread to 27 countries, causing 2,494 cases and 858 deaths (de Wit et al., 2016 , Oh et al., 2018 , WHO, 2020 . In January 2020, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified as the cause of an outbreak of viral pneumonia, which was later named coronavirus disease 2019 and subsequently spread globally (Shu, 2020 , Zhu et al., 2020 . As of August 31, 2020, the outbreak constituted a global pandemic threat, with an exponential increase in the number of patients resulting in 25,275,624 confirmed cases and 846,931 deaths in total. The North American region had the most reported cases, followed by Asia, South America, Europe, Africa, and Oceania (https://ourworldindata.org/coronavirus). The COVID-19 pandemic has impacted all areas of life. Public authorities are taking decisive action to respond to the emerging health threat, leading to reconsideration of the adequacy of pandemic preparedness measures (Dai and Wang, 2020) . After the outbreak of Ebola in 2014, the Global Health Security (GHS) Index was developed to measure the ability of countries to cope with infectious diseases (Aitken et al., 2020) . The GHS Index is the first comprehensive assessment and benchmark of health security and related capabilities across 195 countries (https://www.ghsindex.org/). It considers the broader context of biological risks within each country, including geopolitical considerations, the health system, and the country's capacity to control outbreaks. Questions used to evaluate the GHS Index are organized across six J o u r n a l P r e -p r o o f categories: prevention, detection and reporting, rapid response, health system, compliance with international norms and risk environment. It relies on open-source data from each country. The average overall GHS Index score is 40.2 out of a possible 100. A higher GHS Index indicates better preparedness. Whether the GHS Index can be applied to assess the actual performance of countries during the COVID-19 pandemic has become a hot topic since the outbreak of COVID-19 (Abbey et al., 2020 , Aitken et al., 2020 , Stribling et al., 2020 . Stribling et al. found that the extent of UK pandemic preparedness, expenditure on healthcare, and magnitude of the nursing workforce did not appear to impact the mortality rate of COVID-19 (Stribling et al., 2020) . Abbey et al. reported an overestimation of the preparedness of some countries with a high GHS Index and underestimation of the preparedness of other countries with relatively lower GHS Indexes (Abbey et al., 2020) . Public health measures applied to prevent, detect, and respond to emerging events in countries are essential for controlling infectious disease outbreaks. Many countries have postponed school openings, temporarily shut down businesses and shops, and restricted or prevented crowds from gathering (Adam, 2020 , Jain, 2020 . These emergency measures are not only related to the GHS Index but also have an impact on the epidemic situation, so emergency measures might affect the role that the GHS Index plays in examining the national response to COVID-19 (Chinazzi et al., 2020 , Qian and Jiang, 2020 , Tian et al., 2020 , Wilder-Smith and Freedman, 2020 ). In the current study, we performed a multidimensional association analysis to analyze the correlation between the GHS Index and the epidemic situation of COVID-19 in J o u r n a l P r e -p r o o f different countries (regions) and to estimate the value of the GHS Index in predicting the growth rate of COVID-19 by the time "lockdown" measures are implemented. The GHS Index of each country was extracted from the Global Health Security Index website (https://www.ghsindex.org). COVID-19 data were extracted from the "Coronavirus Pandemic (COVID-19)" database (https://ourworldindata.org/coronavirus), including total cases per million (TCDM) and total deaths per million (TDPM) for different countries (territories or areas). We also retrieved sociological information, including continent, median age, gross domestic product (GDP) per capita, and life expectancy for the corresponding countries. In the first stage of the analysis, we included 178 countries for which there were both GHS Index and COVID-19 data. We excluded 11 countries with a case number <100 or a death number of 0 by August 31, 2020. In the second stage of analysis, we only included 142 countries that adopted "lockdown" measures. Countries with GHS Indexes ranging from 0-33.3, 33.4-66.6, and 66.7-100 were classified into the bottom, middle, and upper (or top) tiers, respectively (https://www.ghsindex.org). Data were independently inputted by two people and checked for consistency. We performed statistical analysis using R version 3.5.1 (https://www.r-project.org/). The TCDM and TDPM were logarithmically transformed before analysis. Continuous J o u r n a l P r e -p r o o f variables are presented as the median and interquartile range (IQR). Categorical variables are expressed as percentiles using contingency tables and were analyzed using the χ 2 test. Differences between groups were compared by using analysis of variance or a nonparametric test. We applied the Spearman correlation coefficient to describe the strength of the correlation between the GHS Index, sociological characteristics, and the epidemic situation of COVID-19. The time of "lockdown" was defined as when the government announced a blockade of areas or cities or closed the country's border. The average daily increase rate (DIR) was estimated by the following formula: DIR = ( √ Total cases of the day Total cases 10 days ago 9 − 1) × 100%. Then, we compared the DIRs of different countries before and after "lockdown" according to the GHS Index level using nonparametric tests. We applied the R package "interplot" to estimate the impact of GHS Index on DIR by the time of "lockdown", which provides a convenient way to visualize the changes in the coefficient of one variable that interacts with another variable (Berry et al., 2016 , Berry et al., 2012 . The significance level was set as 0.05. This study was exempt from ethical approval, as all data were downloaded and accessed from a public database. This study did not include information from individuals, so there was no requirement for informed consent. There were 178 countries that had sufficient data in both the "Coronavirus Pandemic (COVID-19)" and "Global Health Security Index" databases. After excluding 11 countries with <100 COVID-19 cases or 0 deaths, 167 countries remained for analysis. We established this cutoff to ensure reliable exponential growth estimation for each included country while capturing the initial period of outbreaks. Among the included countries, 50 (29.9%) were classified into the bottom tier according to GHS Index, 104 (62.3%) were classified into the middle tier, and 13 (7.8%) were classified into the upper tier. Approximately two-thirds of countries in the bottom tier were African countries. In addition, over 90% of European countries were in the middle and upper tiers. The median TCPM was 1788.87 (IQR, , and the median TDPM was 32.69 (IQR, ). Countries with a higher GHS Index had higher TCPM and TDPM. There was also a significant difference in age, GDP per capita, and life expectancy among countries with different GHS Indices (Table 1) . The framework of the GHS Index includes the following six categories: (1) prevention of the emergence or release of pathogens; (2) early detection and reporting of epidemics of potential international concern; (3) rapid response to an epidemic and mitigation of spread; (4) sufficient and robust health system for treating patients and protecting health workers; (5) commitment to improving national capacity, financing plans to address gaps, and adhering to international norms; and (6) overall risk environment and country vulnerability to biological threats. We used the Spearman rank correlation test to explore the association between the six categories and the confirmed numbers of COVID-19 cases and deaths. As shown in Fig 1, After the outbreak of COVID-19, 142 countries implemented "lockdown" measures. Among the countries included, 41 were located in Africa, 35 in Asia, 38 in Europe, 14 in North America, 11 in South America, and 3 in Oceania. As shown in Fig 2, DIR was significantly different before and after "lockdown" (P<0.001). Countries categorized into different tiers of GHS Index had different DIRs before implementing "lockdown" measures. However, after implementing "lockdown" measures, no significant difference was observed between countries in the middle tier and upper tier (Fig 2) . We further explored the coefficient of the GHS Index in a two-way interaction term conditional on the time of "lockdown" by constructing a fitted linear model with the continent, median age, GDP per capita, and life expectancy as covariates. As shown in The GHS index has been widely applied to identify areas of weakness and opportunities to collaborate across sectors, strengthen health systems, and achieve public health goals. Some scholars have recently offered constructive critiques of the GHS Index's approach to scoring countries' capacity corresponding to the COVID-19 pandemic. In the current study, we performed a multidimensional association analysis to explore the correlation between the GHS Index and COVID-19-associated morbidity and mortality in 178 countries worldwide. We observed a positive association between the GHS Index and COVID-19 cases and deaths but in the opposite manner than expected, meaning that the GHS Index has limited value in reflecting a country's capacity to deal with the global pandemic. Interestingly, the association between the GHS Index and the growth rate of COVID-19 changed from positive to negative after the implementation of "lockdown" measures, showing that the GHS Index can better reflect a country's ability to cope with the local epidemic situation. To the best of our knowledge, this is the first study exploring the correlation between the GHS Index and COVID-19-associated morbidity, mortality, and DIR by considering "lockdown" measures. At present, the whole world is facing an outbreak of a closely related virus for which we currently have no specific therapies or vaccines. It is difficult for countries to prevent SARS-CoV-2 spread due to its specific properties, such as its ability to cause nonspecific functional diseases, its ability to spread from asymptomatic people even before the onset of symptoms, its long incubation period, and the fact that the infectious period even lasts clinical rehabilitation (Hong et al., 2020 , Jin et al., 2020 , Lupia et al., 2020 , Rothan and Byrareddy, 2020 , Ye et al., 2020 . Comprehensive implementation of public health measures to curb the epidemic of COVID-19 is urgently needed, including travel restrictions, cancellation of gatherings, use of face masks in public, hand washing, and social distancing (Cui Hengjian, 2020 , Lyu and Wehby, 2020 , Noorimotlagh et al., 2021 . The GHS Index framework is the first comprehensive assessment tool that evaluates a country's capacity to prevent, detect, and respond to public health emergencies. In addition, the GHS Index considers national political and socioeconomic risks and adherence to international norms, which can influence a country's ability to stop outbreaks. However, in the initial stage of the epidemic, we observed a positive association between the GHS Index and TCPM and TDPM; this association is opposite of what was expected but is similar to the findings of Aitken (Aitken et al., 2020) . It is worth noting that, based on the above results, we cannot arbitrarily assume that the GHS Index has no value. The following issues need to be considered. First, COVID-19 is regarded as a catastrophic infectious disease on a level that has rarely occurred in recent decades, far beyond the control capacity of many countries. which have a significant impact on the national capability to address biological threats. A study demonstrated that only half of countries have strong operational readiness capacities in place, suggesting that they could respond effectively to COVID-19, and collaboration between countries is needed for global outbreak control (Pung et al., 2020) . Second, at the beginning of the outbreak, the ability to detect SARS-CoV-2 was limited by access to test kits. Thus, the number of confirmed cases lagged behind the actual number of patients. This may partly explain why countries with upper-tier GHS Index scores had a higher DIR than countries in the middle or bottom tiers before implementing "lockdown" measures. Third, we observed that DIR was significantly different before and after "lockdown". In the 14 days after lockdown, the ability of early detection and reporting of epidemics was of great importance. This may partly explain why countries with upper-tier and middle-tier GHS Indexes had a higher DIR than countries in the bottom tier. After implementing these strict measures, countries with higher GHS Indexes showed a better capacity to cope with the COVID-19 epidemic. This reveals that the GHS Index has value in assessing a country's ability to respond to a localized epidemic situation. Community resistance to outbreak mitigation measures, hospital transmission, delays in detection and isolation, and lack of funding and resources are the main barriers to the control of COVID-19. COVID-19 poses risks to global health, international J o u r n a l P r e -p r o o f security, and the worldwide economy. Knowing the risks, however, is not enough. Political will is needed to protect people from epidemics, to take action to lessen the burden on overextended health systems, and to build a safer and more secure world. The COVID-19 outbreak is a stark reminder of the ongoing challenge of emerging and re-emerging infectious pathogens. There is an urgent need for constant surveillance, prompt diagnosis, and robust research to understand the basic biology of new organisms and our susceptibilities to them and to develop effective countermeasures (Fauci et al., 2020) . Our study has several limitations. First, testing and diagnostic capacity varied between countries, affecting the confirmed COVID-19 case and death counts. The morbidity and mortality rates reported by different countries might not be accurate. Countries with lower GHS Indexes were more likely to lack the necessary resources for case confirmation, resulting in an underestimation of the number of cases. Second, we used TCPM, TDPM, and DIR to reflect the epidemic situation and control of COVID-19, which may not fully reflect a country's ability to cope with an epidemic or pandemic. Third, although we constructed a fitting linear model with the continent, median age, GDP per capita, and life expectancy as covariates to explore the GHS Index in a twoway interaction term conditional on the time of "lockdown", other potential confounders cannot entirely be excluded and may affect the estimation. In conclusion, the GHS Index was correlated with COVID-19-associated mobility and mortality but in the opposite manner than expected. Implementing "lockdown" measures could significantly reduce the increase in the rate of cases. The GHS Index J o u r n a l P r e -p r o o f has limited value in assessing a country's capacity to respond to a global pandemic. Nevertheless, it has potential value in determining a country's ability to cope with a local epidemic situation. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. All data were downloaded from the public database and followed the data access policies. This study was exempted from ethical review by the ethics committee of Nanjing Medical University. This study did not involve individual information, so there was no requirement for informed consent. Not required. All data generated or analyzed during this study are included in this published article. South America 2 (4.0) 10 (9.6) 0 (0.0) 12 (7.2) Oceania 1 (2.0) 1 (1.0) 1 (7.7) 3 (1.8) Special report: The simulations driving the world's response to COVID-19 Rethinking pandemic preparation: Global Health Security Index (GHSI) is predictive of COVID-19 burden, but in the opposite direction Bias and Overconfidence in Parametric Models of Interactive Processes Improving Tests of Theories Positing Interaction The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak Nonlinear regression in COVID-19 forecasting Origin and evolution of pathogenic coronaviruses Identifying the outbreak signal of COVID-19 before the response of the traditional disease monitoring system SARS and MERS: recent insights into emerging coronaviruses Covid-19 -Navigating the Uncharted Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea Covid-19-lockdown in Mumbai Epidemiology, Pathogenesis, and Control of COVID-19 The effect of human mobility and control measures on the COVID-19 epidemic in China novel coronavirus (2019-nCoV) outbreak: A new challenge Community Use Of Face Masks And COVID-19: Evidence From A Natural Experiment Of State Mandates In The US A systematic review of emerging human coronavirus (SARS-CoV-2) outbreak: focus on disinfection methods, environmental survival, and control and prevention strategies Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures COVID-19 and social distancing The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak Avoid stigmatizing names for 2019 novel coronavirus Examining the UK Covid-19 mortality paradox: Pandemic preparedness, healthcare expenditure, and the nursing workforce An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment Middle East respiratory syndrome coronavirus (MERS-CoV) Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study A Novel Coronavirus from Patients with Pneumonia in China GDP per capita TCPM, total cases per million; TDPM, total deaths per million; GDP, Gross domestic product The authors declare no conflict of interest.